Goldman Sachs analyst David Roman initiates coverage on $Tandem Diabetes Care (TNDM.US)$ with a hold rating, and sets the target price at $46.
According to TipRanks data, the analyst has a success rate of 68.0% and a total average return of 4.7% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Tandem Diabetes Care (TNDM.US)$'s main analysts recently are as follows:
The outlook for insulin pump adoption within the Type 1 diabetes demographic is positive, which is expected to support further market share gains for Tandem Diabetes, bolstered by forthcoming product cycles. Nevertheless, current projections seem to already reflect this optimistic growth trajectory, with additional upside potentially hinging on increased Type 2 diabetes adoption, more significant market share advancements, or a hastened path to profitability.
The significant upside potential for Tandem Diabetes is anticipated due to earnings revisions and multiple expansion. The expected earnings increase is likely to stem from the adoption of Mobi, integration with continuous glucose monitoring systems, and the expansion of Type 2 indications, which could contribute to acquiring new patients and pump renewals. Despite the presence of weight loss drugs, Tandem's global pump market opportunity remains largely untapped.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
